105 related articles for article (PubMed ID: 5534114)
1. Studies on drug resistance. II. Kinase patterns in P815 neoplasms sensitive and resistant to 1-beta-D-arabinofuranosylcytosine.
Drahovsky D; Kreis W
Biochem Pharmacol; 1970 Mar; 19(3):940-4. PubMed ID: 5534114
[No Abstract] [Full Text] [Related]
2. Structural comparison of deoxycytidine kinases purified from cells sensitive (P815) or resistant (P815/ara-C) to 1-beta-D-arabinofuranosylcytosine.
Meyers MB; Kreis W
Cancer Res; 1978 Apr; 38(4):1099-104. PubMed ID: 639039
[No Abstract] [Full Text] [Related]
3. Comparison of enzymatic activities of two deoxycytidine kinases purified from cells sensitive (P815) or resistant (P815/ara-C) to 1-beta-D-arabinofuranosylcytosine.
Meyers MB; Kreis W
Cancer Res; 1978 Apr; 38(4):1105-12. PubMed ID: 25131
[No Abstract] [Full Text] [Related]
4. Characterization of protein and DNA in P815 cells sensitive and resistant to 1- -D-arabinofuranosylcytosine.
Kreis W; Drahovsky D; Borberg H
Cancer Res; 1972 Apr; 32(4):696-701. PubMed ID: 4622581
[No Abstract] [Full Text] [Related]
5. Studies on drug resistance. I. Distribution of l-beta-D-arabinofuranosylcytosine, cytidine and deoxycytidine in mice bearing ara-C-sensitive and-resistant P815 neoplasms.
Uchida K; Kreis W
Biochem Pharmacol; 1969 May; 18(5):1115-28. PubMed ID: 5789778
[No Abstract] [Full Text] [Related]
6. Phosphorylation of selected substrates by semipurified cytoplasmic kinases of three P815 murine leukemias exhibiting collateral sensitivity (P815/TG), sensitivity (P815) or resistance (P815/ARA-C) to 1-beta-D-arabinofuranosylcytosine.
Kreis W; Graham J; Damin LA
Biochem Pharmacol; 1982 Dec; 31(23):3831-7. PubMed ID: 6297500
[No Abstract] [Full Text] [Related]
7. Deoxycytidine kinase. I. Distribution in normal and neoplastic tissues and interrelationships of deoxycytidine and 1-beta-D-arabinofuranosylcytosine phosphorylation.
Durham JP; Ives DH
Mol Pharmacol; 1969 Jul; 5(4):358-75. PubMed ID: 4308509
[No Abstract] [Full Text] [Related]
8. Biochemical and genetic studies of a mutant strain of mouse leukemia L1210 resistant to 1-beta-D-arabinofuranosylcytosine (Cytarabine).
Bach MK
Cancer Res; 1969 May; 29(5):1036-44. PubMed ID: 5781095
[No Abstract] [Full Text] [Related]
9. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: nucleoside and nucleotide kinases in cell-free extracts.
Schrecker AW
Cancer Res; 1970 Mar; 30(3):632-41. PubMed ID: 5425288
[No Abstract] [Full Text] [Related]
10. Physiologic disposition of cytosine arabinoside and its derivatives in man.
Kreis W; Woodcock TM; Meyers MB; Carlevarini LA; Krakoff IH
Cancer Treat Rep; 1977 Jul; 61(4):723-6. PubMed ID: 195729
[TBL] [Abstract][Full Text] [Related]
11. Kinase and deaminase activity in a variety of subcutaneous mouse tumors.
Furner RL; Mellett LB
Cancer Res; 1975 Jul; 35(7):1799-803. PubMed ID: 165884
[TBL] [Abstract][Full Text] [Related]
12. Determinants in chemosensitivity of oncogene-transformed NIH3T3 cells to 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine.
Zhang M; Endo Y; Sasaki T
Int J Oncol; 1999 Mar; 14(3):543-9. PubMed ID: 10024689
[TBL] [Abstract][Full Text] [Related]
13. Purification of deoxycytidine kinases from two P815 murine neoplasms and their separation from deoxyguanosine kinase.
Meyers MB; Kreis W
Arch Biochem Biophys; 1976 Nov; 177(1):10-5. PubMed ID: 999281
[No Abstract] [Full Text] [Related]
14. Studies in mouse L-cells on the incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate.
Graham FL; Whitmore GF
Cancer Res; 1970 Nov; 30(11):2636-44. PubMed ID: 5530558
[No Abstract] [Full Text] [Related]
15. Resistance of mammalian tumour cells toward pyrimidine analogues. A review.
Veselỳ J; Cihák A
Oncology; 1973; 28(3):204-26. PubMed ID: 4129030
[No Abstract] [Full Text] [Related]
16. Effect of 1-beta-D-arabinofuranosylcytosine on DNA synthesis. 1. In normal rabbit kidney cell cultures.
Kaplan AS; Brown M; Ben-Porat T
Mol Pharmacol; 1968 Mar; 4(2):131-8. PubMed ID: 5645610
[No Abstract] [Full Text] [Related]
17. Combinations of tetrahydrouridine and cytosine arabinoside in mouse tumors.
Kreis W; Hession C; Soricelli A; Scully K
Cancer Treat Rep; 1977 Oct; 61(7):1355-64. PubMed ID: 589601
[TBL] [Abstract][Full Text] [Related]
18. Influence of tetrahydrouridine on the phosphorylation of 1-beta-D-arabinofuranosyl-cytosine (ara-C) by enzymes from solid tumors in vitro.
Furner RL; Mellett LB; Herren TC
J Pharmacol Exp Ther; 1975 Jul; 194(1):103-10. PubMed ID: 1057009
[TBL] [Abstract][Full Text] [Related]
19. Distribution of kinase and deaminase of 1-beta-D-arabinofuranosylcytosine in tissues of man and mouse.
Ho DH
Cancer Res; 1973 Nov; 33(11):2816-20. PubMed ID: 4518302
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine in humans.
Wan SH; Huffman DH; Azarnoff DL; Hoogstraten B; Larsen WE
Cancer Res; 1974 Feb; 34(2):392-7. PubMed ID: 4521089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
